Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
The Global Training Day, Bangalore
April 9 was a day filled with enthusiasm as we set forth with “The Drupal Global Day training” here at Valuebound. With a crowd of over 20 people and 5 trainers the knowledge sharing session…
|
How to build your Drupal 8 theme using Bootstrap & Less
Bootstrap is a true blessing for web developers which is a sleek, intuitive and powerful mobile first front-end framework for faster and easier web development. When you mix that with LESS pre-…
|
How to write the custom Drush Commands in Drupal 8?
Writing own drush command is quite easy, In Drupal 8 is not exactly like Drupal 7 but it is similar. Here also, we are implementing hook_drush_command().
|
How to reduce the risk of your Drupal 8 application using Backup & Restore?
This article will save you from that dreadful situation. Not only is creating and storing site backup a good practise, but it also ensures site stability and helps in further updation.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
